As of 1:44pm ET
| +0.0319 / +8.73%|
The 1 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 0.60, with a high estimate of 0.60 and a low estimate of 0.60. The median estimate represents a +51.02% increase from the last price of 0.40.
The current consensus among 2 polled investment analysts is to Hold stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.